2017Chin J Cardiovasc MedRequires access

Prognostic impact of direct percutaneous coronary intervention on non-infarction related artery simultaneously on ST-segment elevation myocardial infarction in patients with multivessel disease

Miao Lin, Wentao Zhao, Minxia Zhang, Tongbin Li

Open publisher page 0 citations

Abstract

Objective To investigate the prognosis of direct percutaneous coronary intervention(PCI)on infarction related artery(IRA)and simultaneously on non-infarct related artery(non-IRA)on ST-segment elevation myocardial infarction(STEMI)patients with multivessel disease. Methods The178 patients with STEMI multivessel disease were enrolled into this study in Department of Cardiology, XiJing Hospital of Fourth Military University, from Janurary of 2015 to June of 2016.All patients were divided into multivessel primary PCI group(42 cases)and staged PCI group(136 cases)based on the interventional timing of non-IRA.The data of PCI and the complications during hospitalization were compared between the two groups.Patients were followed up for one year, and the levels of left ventricular ejection fraction(LVEF)and the rates of major adverse cardiovascular events(MACE)were compared between the two groups. Results Compared with the staged PCI group, the hospitalization time [(5.5±1.5)d vs.(9.5±1.5)d, t=3.97, P=0.02] and hospitalization cost [RMB: (46 765±20 242)yuan vs.(54 884±22 885)yuan, t=3.88, P=0.04] were significantly lower in the primary PCI group; however, the perioperative complications increased in primary PCI group, while without statistically difference [6 cases(14.3%)vs.13 cases(9.6%), χ2=0.61, P=0.40]. Meanwhile, incidence of MACE had no significant difference between two groups in one year after PCI [10 cases(23.8%)vs.24 cases(17.6%), χ2=0.79, P=0.38]. LVEF in primary PCI group was significant higher compared with staged PCI group(59.7%±3.4% vs.55.0%±4.1%, t=3.87, P=0.04). Conclusions Direct PCI on non-IRA simultaneously on STEMI patients with multivessel disease may reduce hospitalization time and hospitalization expenses, reduce contrast dose, improve LVEF without increase of complications and incident of MACE.Therefore, it could be used as a strategy for STEMI patients by direct PCI if the estimated successful rate is high enough. Key words: Myocardial infarction; Non infarct related artery; Angioplasty, transluminal, percutaneous coronary

About this research paper

What this paper is about

Objective To investigate the prognosis of direct percutaneous coronary intervention(PCI)on infarction related artery(IRA)and simultaneously on non-infarct related artery(non-IRA)on ST-segment elevation myocardial infarction(STEMI)patients with multivessel disease. Methods The178 patients with STEMI multivessel disease were enrolled into this study in Department of Cardiology, XiJing Hospital of Fourth Military University, from Janurary of 2015 to June of 2016.All patients were divided into multivessel primary PCI group(42 cases)and staged PCI group(136 cases)based on the interventional timing of non-IRA.The data of PCI and the complications during hospitalization were compared between the two groups.Patients were followed up for one year, and the levels of left ventricular ejection fraction(LVEF)and the rates of major adverse cardiovascular events(MACE)were compared between the two groups. Results Compared with the staged PCI group, the hospitalization time [(5.5±1.5)d vs.(9.5±1.5)d, t=3.97, P=0.02] and hospitalization cost [RMB: (46 765±20 242)yuan vs.(54 884±22 885)yuan, t=3.88, P=0.04] were significantly lower in the primary PCI group; however, the perioperative complications increased in primary PCI group, while without statistically difference [6 cases(14.3%)vs.13 cases(9.6%), χ2=0.61, P=0.40]. Meanwhile, incidence of MACE had no significant difference between two groups in one year after PCI [10 cases(23.8%)vs.24 cases(17.6%), χ2=0.79, P=0.38]. LVEF in primary PCI group was significant higher compared with staged PCI group(59.7%±3.4% vs.55.0%±4.1%, t=3.87, P=0.04). Conclusions Direct PCI on non-IRA simultaneously on STEMI patients with multivessel disease may reduce hospitalization time and hospitalization expenses, reduce contrast dose, improve LVEF without increase of complications and incident of MACE.Therefore, it could be used as a strategy for STEMI patients by direct PCI if the estimated successful rate is high enough. Key words: Myocardial infarction; Non infarct related artery; Angioplasty, transluminal, percutaneous coronary

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To investigate the prognosis of direct percutaneous coronary intervention(PCI)on infarction related artery(IRA)and simultaneously on non-infarct related artery(non-IRA)on ST-segment elevation myocardial infarction(STEMI)patients with multivessel disease. Methods The178 patients with STEMI multivessel disease were enrolled into this study in Department of Cardiology, XiJing Hospital of Fourth Military University, from Janurary of 2015 to June of 2016.All patients were divided into multivessel primary PCI group(42 cases)and staged PCI group(136 cases)based on the interventional timing of non-IRA.The data of PCI and the complications during hospitalization were compared between the two groups.Patients were followed up for one year, and the levels of left ventricular ejection fraction(LVEF)and the rates of major adverse cardiovascular events(MACE)were compared between the two groups. Results Compared with the staged PCI group, the hospitalization time [(5.5±1.5)d vs.(9.5±1.5)d, t=3.97, P=0.02] and hospitalization cost [RMB: (46 765±20 242)yuan vs.(54 884±22 885)yuan, t=3.88, P=0.04] were significantly lower in the primary PCI group; however, the perioperative complications increased in primary PCI group, while without statistically difference [6 cases(14.3%)vs.13 cases(9.6%), χ2=0.61, P=0.40]. Meanwhile, incidence of MACE had no significant difference between two groups in one year after PCI [10 cases(23.8%)vs.24 cases(17.6%), χ2=0.79, P=0.38]. LVEF in primary PCI group was significant higher compared with staged PCI group(59.7%±3.4% vs.55.0%±4.1%, t=3.87, P=0.04). Conclusions Direct PCI on non-IRA simultaneously on STEMI patients with multivessel disease may reduce hospitalization time and hospitalization expenses, reduce contrast dose, improve LVEF without increase of complications and incident of MACE.Therefore, it could be used as a strategy for STEMI patients by direct PCI if the estimated successful rate is high enough. Key words: Myocardial infarction; Non infarct related artery; Angioplasty, transluminal, percutaneous coronary

Key concepts: Conventional PCI, Medicine, Mace, Percutaneous coronary intervention, Cardiology, Myocardial infarction, Internal medicine, Ejection fraction

Back to paper searchBrowse research topicsOriginal source
Prognostic impact of direct percutaneous coronary intervention on non-infarction related artery simultaneously on ST-segment elevation myocardial infarction in patients with multivessel disease — Research Paper | ScholarLens